Casdin Capital LLC 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-04 7:46 pm Purchase | 2025-02-28 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 80,864,315 21.600% | 7,098,241 (+9.62%) | Filing |
| 2024-08-14 8:54 pm Purchase | 2024-08-12 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 73,766,074 19.770% | 8,468,478 (+12.97%) | Filing |
| 2024-01-09 5:13 pm Purchase | 2024-01-05 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 65,297,596 19.710% | 27,715,250 (+73.75%) | Filing |
| 2022-04-08 5:07 pm Purchase | 2022-04-04 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 37,582,346 32.740% | 37,582,346 (New Position) | Filing |